#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Keratosis follicular Hyperphagia Short-bowel syndrome B-cell small lymphocytic lymphoma recurrent Pouchitis ABO haemolytic disease of newborn Astrocytoma malignant Hepatobiliary cancer Small intestine neuroendocrine tumour Dermatomyositis Obesity MELAS syndrome Follicular lymphoma stage III Emphysema Cutaneous T-cell lymphoma stage II More trials…

    Learn about Rare Diseases

    Mastocytosis – Life with Disease Testicular leiomyosarcoma – Diagnostics Mast cell activation syndrome – Life with Disease Myelodysplastic syndrome with excess blasts – Life with Disease Osteosarcoma – Diagnostics Encephalitis autoimmune – Treatment Haemophilia A without inhibitors – Life with Disease Progressive supranuclear palsy – Treatment Pleural mesothelioma malignant – Trials in Disease Ewing’s sarcoma metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000039711 Degarelix Acetate Artemisia Vulgaris (312) Rbl012.2 Entrectinib Inavolisib Alks 2680 ULTEVURSEN Ly3541860 Bay 3018250 Tiapride Eftilagimod Alfa Epinephrine Bitartrate Ambrisentan Alectinib Hydrochloride Pioglitazone Hydrochloride 20-HYDROXYECDYSONE Brepocitinib Tosilate Neratinib SODIUM BENZOATE More therapies…

    Learn about Your Condition

    Vaginal cancer Rectal cancer stage III Rectosigmoid cancer ROHHAD syndrome Chronic myeloid leukaemia Alveolar rhabdomyosarcoma Metastases to lymph nodes Diabetic foot Staphylococcal bacteraemia Dedifferentiated liposarcoma Microscopic polyangiitis Muscular dystrophy Insomnia Anxiety disorder Pulmonary embolism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to assess the safety of RJVA-001 in adults with type 2 diabetes that is not well controlled by current medications.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • ADENO-ASSOCIATED VIRUS SEROTYPE 9 CONTAINING THE HUMAN GCG GENE
    The Netherlands

  • A study to evaluate the safety and effectiveness of nivolumab and imiquimod in adults with vulvar squamous cell carcinoma

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Imiquimod
    • Nivolumab
    France

  • A study to evaluate the use of colchicine to reduce inflammation in patients with deep vein thrombosis.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Deep vein thrombosis
    • Pelvic venous thrombosis
    Investigated Drugs:
    • Colchicine
    Italy

  • Effect of semaglutide, acetylsalicylic acid, and clopidogrel on blood clotting in patients with diabetes or overweight with cardiovascular disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Obesity
    • Overweight
    Investigated Drugs:
    • Clopidogrel
    • Acetylsalicylic Acid
    • Semaglutide
    Italy

  • A study of RVU120 and everolimus for children with recurrent or progressive medulloblastoma

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    • Everolimus
    Poland

  • Study of ezabenlimab in patients with locally advanced head and neck cancer who have remaining signs of disease after chemoradiotherapy

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Ezabenlimab
    Belgium
Previous Page
1 … 718 719 720 721 722 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!